Overview
- Mexico’s Health Ministry has confirmed a mid‑October launch for the combined influenza and COVID‑19 campaign, with reports citing either Oct. 13 or Oct. 15 as the start and an end date of April 3, 2026.
- Shots will be available at no cost across IMSS, ISSSTE, IMSS‑Bienestar, Pemex and state services, with mobile brigades to reach rural and hard‑to‑access communities.
- The program will use a tetravalent inactivated influenza vaccine and updated mRNA COVID‑19 boosters (Spikevax and Comirnaty LP.8.1), which may be administered on the same day, even in the same arm with 2.5–5 cm separation.
- Priority groups include children 6 months to 4 years 11 months, adults 60 and older, pregnant women, health workers, and people 5–59 with comorbidities, with a national coverage goal of at least 70% by December 26, 2025.
- In Spain’s Asturias, vaccinations start October 14 with the COVID‑19 booster recommendation raised to age 70 and first‑time use of the Spanish Hypra vaccine alongside Pfizer, with care‑home residents immunized first.